Annals of Family Medicine

NOVEMBER 20, 2024

Intervention: Our findings have been used to refine a food insecurity screening and assessment tool that we co-designed, pilot tested, and evaluated in partnership with community paramedics embedded in a FHT in 2023-24. Most felt that their interactions with dietitians had been unhelpful.

Primary Care 130

Primary Care Screening Family Doctor Mental Health 130

Common Sense Family Doctor

DECEMBER 27, 2024

Don Berwick's dire warning about the existential threat of greed on the failing American health care system seems to be coming true, to the extent that the brazen assassination of an insurance company executive in midtown Manhattan elicited far more outrage about delayed or denied care than sympathy for his family's loss.

Primary Care 52

Primary Care Insurance Patient-Centered Medical Student 52

Common Sense Family Doctor

JUNE 8, 2025

The authors urged readers to make the elimination of nuclear weapons an urgent public health priority, reiterating a 2023 editorial on similar themes : Any use of nuclear weapons would be catastrophic for humanity.

Transportation 80

Transportation Government Education Community 80

Common Sense Family Doctor

MAY 1, 2025

Clinical practice guidelines on the management of episodic migraine headache, including the 2023 US Veterans Affairs/Department of Defense guideline , preferentially recommend triptans for most patients.

Primary Care 52

Primary Care Family Physician Clinical Practice Diagnose 52

Common Sense Family Doctor

MAY 30, 2025

A 2020 meta-analysis of eight randomized controlled trials (summarized in a POEM in American Family Physician ) concluded that low-dose CT screening prevents one lung cancer death for every 250 people screened. to 3.33, indicating that even the most pragmatic studies fell well short of simulating conditions in community settings.

Primary Care 59

Primary Care Screening Family Physician Family Medicine 59

Common Sense Family Doctor

FEBRUARY 1, 2025

Practices developed novel workflows to support TCM and to ensure that it is financially sustainable, as reviewed in a 2023 article in FPM.

Hospital 52

Hospital Management Primary Care Primary Care Physician 52

Common Sense Family Doctor

FEBRUARY 15, 2025

On Sensible Medicine, Dr. Edward Livingston pointed out that the manufacturer, AbbVie, spent $580 million on DTCA for this drug in 2023, or $290 for each of the 2 million potential patients in the United States. The annual price of risankizumab is $288,000, so this is still a huge bargain for the company given the potential returns.

Family Physician 40

Family Physician Manufacturing Families Family 40